These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4394302)

  • 1. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR; Robson RD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the mechanism of the antiarrhythmic effect of beta-adrenergic receptor blocking drugs. Experimental research using 2 isomers of butidrin].
    Mastandrea R; Malagnino G; Astorri E; Visoli O
    Boll Soc Ital Cardiol; 1967; 12(5):525-8. PubMed ID: 5606898
    [No Abstract]   [Full Text] [Related]  

  • 3. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 4. [Butydrine in the treatment of arrhythmia caused by hypertensive drugs in the course of fluothane anesthesia].
    Leonardis G; Splendiani G; Azzarone G
    Minerva Anestesiol; 1969 Oct; 35(10):1017-20. PubMed ID: 4394402
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR; Somani P
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiarrhythmic effect of butidrine: experimental study on arrhythmias induced by N-adrenaline in halothane anesthesia].
    Rossano C; Romoli M; Brunozzi LT; Monti GB; Pavoni P
    Acta Anaesthesiol; 1969; 20(4):663-700. PubMed ID: 4397385
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
    Madan BR; Vyas DS
    Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M; Imamura H; Nakamura T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiarrhythmic action of penbutolol].
    Boissier JR; Coutte R; Bertin MC; Giudicelli JF
    Therapie; 1974; 29(2):261-9. PubMed ID: 4152641
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism of cardiac arrhythmias by beta-adrenoreceptor blocking agents.
    Laddu AR; Kumakura S; Somani P
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):168-81. PubMed ID: 4404932
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
    Somani P
    Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiarrhythmic effect of blocking agent of beta-adrenergic receptors napriline].
    Gorodinskaia VIa
    Farmakol Toksikol; 1969; 32(1):43-7. PubMed ID: 5770314
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J; Arconada JA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of an adrenergic beta-receptor-blocking agent on cardiac rhythm disturbances in experimental barium poisoning].
    Lydtin H; Kusus T; Dietze G; Schnelle K
    Arzneimittelforschung; 1967 Nov; 17(11):1456-9. PubMed ID: 5632168
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of the beta-adrenergic blocking agent H56-28 in arrhythmias].
    Cárdenas M; Brenes C; Ruipérez JA; Hermosillo JA
    Arch Inst Cardiol Mex; 1968; 38(5):692-706. PubMed ID: 4178511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of the effects of beta-adrenergic blocking in heart diseases, with special reference to disorders of rhythm and circulation].
    Fassini G; Saurgnani E; Agliati G; Marangoni R
    Minerva Cardioangiol; 1967 Jan; 15(1):83-122. PubMed ID: 4386133
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of dextro-alprenolol, dextro-propranolol and practolol in the treatment of ventricular ectopic beats.
    Smith E; Bennet D; Sowton E
    Guys Hosp Rep; 1971; 120(1):9-15. PubMed ID: 4397736
    [No Abstract]   [Full Text] [Related]  

  • 20. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents.
    Shalsha KG
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.